miR-31, a reported target of hif1a, was increased in specimens obtained from patients with active ulcerative colitis [31] and during progression and neoplastic transformation of IBD, [32] but it was down-regulated in NEC tissues (0.12 fold). Here, HIF1A is linked to inflammatory bowel disease.